Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (191-200 of 431) with videos related to

Pageof 44
Sort By:
Endocrine|November 10, 2014
Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Current Molecular Medicine|September 19, 2019
Molecular Links Between Alzheimer's Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection InvolvementTaxiarchis Katsinelos, Michael Doulberis, Stergios A Polyzos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2024
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Endocrine|March 23, 2024
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?Anastasios Serbis, Stergios A Polyzos, Stavroula A Paschou, et al.
Metabolism: Clinical and Experimental|January 29, 2019
Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2026
Helicobacter pylori infection with metabolic-associated fatty liver disease and Colorectal NeoplasmsJannis Kountouras, Nikolaos Kapetanakis, Stergios A Polyzos, et al.
Journal of Crohn'S & Colitis|December 31, 2021
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic AgentsApostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, et al.
Pituitary|March 17, 2011
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experiencePanagiotis Anagnostis, Fotini Adamidou, Stergios A Polyzos, et al.
Expert Opinion on Pharmacotherapy|January 3, 2020
Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescentsMichael Doulberis, Stergios A Polyzos, Apostolis Papaefthymiou, et al.
Arquivos De Gastroenterologia|October 9, 2014
Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label studyStergios A Polyzos, Panagiotis Nikolopoulos, Angeliki Stogianni, et al.
Pageof 44

Showing results (191-200 of 431) with videos related to

Sort By:
Pageof 44
Endocrine|November 10, 2014
Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Current Molecular Medicine|September 19, 2019
Molecular Links Between Alzheimer's Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection InvolvementTaxiarchis Katsinelos, Michael Doulberis, Stergios A Polyzos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2024
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Endocrine|March 23, 2024
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?Anastasios Serbis, Stergios A Polyzos, Stavroula A Paschou, et al.
Metabolism: Clinical and Experimental|January 29, 2019
Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2026
Helicobacter pylori infection with metabolic-associated fatty liver disease and Colorectal NeoplasmsJannis Kountouras, Nikolaos Kapetanakis, Stergios A Polyzos, et al.
Journal of Crohn'S & Colitis|December 31, 2021
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic AgentsApostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, et al.
Pituitary|March 17, 2011
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experiencePanagiotis Anagnostis, Fotini Adamidou, Stergios A Polyzos, et al.
Expert Opinion on Pharmacotherapy|January 3, 2020
Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescentsMichael Doulberis, Stergios A Polyzos, Apostolis Papaefthymiou, et al.
Arquivos De Gastroenterologia|October 9, 2014
Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label studyStergios A Polyzos, Panagiotis Nikolopoulos, Angeliki Stogianni, et al.
Pageof 44